|
|
|
|
|
FCRA Receipt
1-Apr-2013 to 31-Mar-2016
| Date |
Particulars |
Amount Received |
| 18-Oct-2013 |
EISAI Pharmaceuticals India |
18,00,000 |
| 15-Jan-2014 |
BMS India |
5,00,000 |
| 4-Feb-2014 |
Medpace ChemGenix |
4,53,885 |
| 24-Mar-204 |
Sequoia Capital I |
3,00,000 |
| 08-Dec-2014 |
American Society of Clinical Oncology |
5,78,853 |
| 17-Mar-2015 |
Sequoia Capital I |
3,45,000 |
| 31-Mar-2015 |
EISAI Pharmaceuticals India |
50,000 |
| 31-Mar-2015 |
EISAI Pharmaceuticals India |
30,000 |
| 16-Jun-2015 |
GLOBAL SEVA FUND |
99,652 |
| 14-Aug-2015 |
Merck Specialities Pvt. Ltd. |
11,76,000 |
| 10-Sep-2015 |
Reche India |
49,00,000 |
| 19-Oct-2015 |
Novarties India |
98,000 |
| 31-Dec-2015 |
European Society of Medical Oncology |
3,92,100 |
| 25-Jan-2016 |
Eli Litty & Co India Pvt Ltd. |
4,90,000 |
| 03-Feb-2016 |
Abbott Healthcare |
5,00,000 |
| 05-Feb-2016 |
Merck Specialities Pvt. Ltd. |
2,54,800 |
| 23-Mar-2016 |
Sequoia Capital I |
9,00,000 |
| 28-Mar-2016 |
Boehringer Ingeltheim |
9,80,000 |
| 28-Mar-2016 |
Boehringer Ingeltheim |
1,47,000 |
| |
|
|
| |
|
1,39,95,289 |
|
|
|
|
|
|